Santarus Tries To Shoot Down Zydus' Generic Zegerid

Law360, Los Angeles (December 23, 2011, 2:06 PM EST) -- Santarus Inc. and the University of Missouri on Wednesday struck Zydus Pharmaceuticals USA Inc. with a patent infringement suit in New Jersey federal court, continuing an ongoing fight to block generic versions of the heartburn drug Zegerid.

The lawsuit was launched in response to Zydus filing an abbreviated new drug application with the U.S. Food and Drug Administration regarding its intent to market a generic version of the drug before Santarus' patents expire. Zydus notified Santarus in November that it was seeking approval to market a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.